EMTRICITABINE\TENOFOVIR DISOPROXIL: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
29.8%
Female
70.2%
Male
Age Information
The average age of patients reporting adverse events with EMTRICITABINE\TENOFOVIR DISOPROXIL is 46.1 years.
Geographic Distribution
The majority of adverse event reports for EMTRICITABINE\TENOFOVIR DISOPROXIL originate from US.
Report Summary & Outcomes
39,362
Total Reports
39,362
As Primary/Secondary Suspect
1,254
Deaths Reported
4,560
Hospitalizations
452
Life-Threatening
337
Disabilities
Reporting Timeline
First adverse event report: 1989. Most recent report: 20250826. View full timeline →